Edwards Lifesciences announced today that it exercised its option to acquire Innovalve Bio Medical. BTIG analysts say that Edwards expects to pay $300 million in cash at closing. Irvine, California–based Edwards made its initial investment in Innovalve in 2017. It says the company has since demonstrated progress with promising early clinical evidence for its transcatheter […]